Thursday, February 9, 2023

Immune Exhaustion Emerges After 3rd Vaccine Dose: Current Findings

Is it possible that the whole point of this CCP Military program was to make the victim susceptable to AIDs like immune system response?  You can die frrom the common cold long after the original viral agency has lost its pep and it is the JAB that is designed to do you in.

If the JAB has done its job, then 4,000,000,000 folks have seriously weakened immune systems.  This may not actually be true for a number of reasons, but this does look like the original intent.

Read slowly what i just said.  Did you dismiss it?  Also understand that millions were bribed knowingly or even unknowingly and are all now in line for a summary  banding while actual behavior is investigated.

Immune Exhaustion Emerges After 3rd Vaccine Dose: Current Findings

Finding suggests how little we know about the immune system

Jan 30 2023

Vaccines have been upheld as the best strategy for dealing with infectious diseases, but that’s largely because of a limited understanding of the immune system and how to best complement and support its function. Our bodies are normally able to separate the wheat from the chaff when it comes to invading pathogens or when a vaccine stimulates an immune reaction, but there are factors that can compromise that.

A study published in Science Immunology in January 2023 (but first submitted in August 2022) shows that incremental doses of the mRNA COVID-19 vaccine boosters may be one such factor, based on how they train our immune systems. In this case, the immune system seemed to gain a false sense of security from dealing with the booster version of the vaccine, which is supposed to teach the immune system how to deal with the virus. Unfortunately, in this case, it seemed that the immune system has learned that it doesn’t need to mount a strong counterattack. Worse, the vaccine boosters might not even induce any effect in people at high risk of severe infection.

IgG Subtype Composition Changed After Vaccination

According to the study, the third dose of the mRNA vaccines seems to be linked with a class switch in subtypes of immunoglobulin G (IgG), the dominating serum antibody in our immune system, which raises the question of immune exhaustion. Class switching is when B cells redirect their efforts toward producing IgG. To start, they produce generic immunoglobulin cells such as IgM. But once they find that the invading pathogen is tougher than they thought, they switch to producing the more effective IgG to ward off the infection.

IgG is an important serum antibody that makes up roughly 80 percent of all antibodies in our immune system. After class switching occurs, B cells release different types of IgG instead of other less-effective immunoglobulin cells. Depending on the severity of the infection, the ratio of IgG may also vary.

IgG is the more effective fighter in our immune system, as it has the ability to opsonize and fixate complements, meaning that it attaches to infected cells or pathogens and instructs killer cells to swallow intruders up through phagocytosis. It’s also the only antibody that crosses into the placenta, playing a critical role in protecting the unborn fetus.

The roles that IgG plays in our immune system are critical to our health. (The Epoch Times)

However, IgG is split up into four major subtypes—denoted IgG1 through IgG4—and each has its own strengths and limitations.

Out of all four, IgG1 makes up most of serum IgG, as it has the best immune properties. Along with IgG3, these two are the most potent members of the IgG family.

IgG4 is considered one of the weakest types, as it doesn’t do as well in attracting immune cells responsible for eliminating invaders.

Research shows that IgG4 composition usually hovers at about 4 percent, a number matched by the aforementioned study for patients after five months of receiving the second dose of vaccine.

Right after the second dose, IgG4 levels were at 0.04 percent while IgG1 and IgG3—the most potent members in the IgG family—made up 96.55 percent of all IgG, according to the aforementioned Science Immunology paper.

This change in IgG levels indicates that the body interprets the second dose as a serious infection and produces the more effective IgG to tackle the simulated infection. However, things look a little different after the vaccine booster shot.

In the study, the percentage of IgG4 in the blood serum rose to unexpectedly high levels after the third dose. Ten days after the third vaccination, IgG4 levels rose to 13.91 percent and jumped to 19.27 percent five months after. At the same time, IgG1 and IgG3 levels both dropped, showing a significant change in blood serum antibody composition.


Data shows that the composition of IgG subtypes changes drastically after the third dose of an mRNA vaccine. (The Epoch Times)

This isn’t good, as higher levels of IgG4, without the ability to stimulate immune cells, could indicate immune exhaustion. It’s also an indication that the immune system intentionally dampened the response starting with the third dose of the vaccination.

On the other hand, although IgG3 and IgG1 contribute the most to immune mechanisms, the downside is that they’re costly to produce and can quickly wear out the body. In contrast, IgG4 isn’t as effective but it’s more economical to produce.

The immune system will always place warding off outside intruders at the top of its to-do list while keeping efficiency in mind. This is why the amount of each IgG subtype produced varies with each infection.

In the Science Immunology study, high IgG4 levels after the third dose, even a long time after it, indicate that the immune system is being worn out through the repeated vaccination course. The body treats the third dose with more indifference and deploys the less effective IgG4 in response.

This development of more IgG4 than usual is unhealthy and riskier for people if they encounter the real virus later, as COVID-19 can develop into a rather severe disease, especially for people with chronic conditions. If the body begins to treat the SARS-CoV-2 vaccine like a boy crying wolf, then what if the real virus comes knocking at the door?

The vaccine is meant to train the immune system’s memory cells so that the next time something similar comes along, they know how to quickly defend the immune system. This process is also called antibody acquisition. The aforementioned study demonstrates that the body stops regarding COVID-19 as a serious viral infection after the vaccine booster shot. However, in some people, the boosters actually have no effect at all.
Antibody Acquisition Rates ‘Extremely Low’ for Organ Transplant Recipients, Studies Show

One group of people who might gain the least from vaccination seems to include those who are immunocompromised, such as organ transplant recipients—people who regularly take immunosuppressants as a part of post-operational procedures.

A study published in Nature shows that antibody acquisition rates against COVID-19 were “extremely low” in kidney transplant patients. This finding contradicts the purpose of the vaccine, as it’s meant to induce antibody acquisition.

Organ transplant patients struggle to neutralize antibodies from the third dose of the mRNA COVID-19 vaccines. (The Epoch Times)

Similar reports have also surfaced elsewhere, especially in regard to newer variants of COVID-19. An observational study claiming to be the largest when analyzing four-dose vaccinated organ transplant recipients shows that the mRNA vaccine booster demonstrates a “lack of formal neutralization” against “variants of concern including Omicron.”

Data published by Elsevier also shows that antibody neutralization against the Omicron coronavirus variant has seen a 15- to 20-fold reduction when compared with the wild-type virus in transplant recipients. These findings are of grave concern.

The U.S. Centers for Disease Control and Prevention still recommends that immunocompromised people receive a COVID-19 vaccine, as well as get their vaccine boosters.

According to data published in the medical journal Transplantation, during the recent Omicron wave, although COVID-19 cases have increased for organ transplant recipients, the death rate of this population has dropped fivefold.


Organ transplant recipients see an uptick in cases yet a lowered mortality rate during the Omicron surge. (The Epoch Times)

However, is this reduction due to repeated vaccination or to the reduced pathogenicity of Omicron variants? Is it really effective to drive vaccination campaigns for the immunocompromised, based on the trifling level of antibody acquisition? Can the benefits of repetitive boosting outweigh the increased risk of side effects?

It’s really time to reconsider what place the COVID-19 vaccines should take. Are we underestimating the wisdom of our immune system? This stance is similar to that taken in a previous article that mentions how “negative efficacy” should have stopped vaccine recommendations in their tracks.

Now, researchers are saying that vaccines, especially boosters, fail to have a significant effect on the immunocompromised—the very group of people especially susceptible to severe disease and death. We need to stop placing the mRNA shots on a pedestal and consider all options in response to SARS-CoV-2, such as focusing on bolstering our natural immune system and holistic well-being.

No comments: